SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001013594-20-000133
Filing Date
2020-02-13
Accepted
2020-02-13 10:09:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 DECEMBER 31, 2019 eigerpharm13ga2-123119.htm SC 13G/A 83713
  Complete submission text file 0001013594-20-000133.txt   85171
Mailing Address 3 COLUMBUS CIRCLE SUITE 2205 NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE SUITE 2205 NEW YORK NY 10019 (212) 554-2379
683 Capital Management, LLC (Filed by) CIK: 0001404574 (see all company filings)

IRS No.: 205100992 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 350 CAMBRIDGE AVENUE SUITE 350 PALO ALTO CA 94306
Business Address 350 CAMBRIDGE AVENUE SUITE 350 PALO ALTO CA 94306 650-272-6138
EIGER BIOPHARMACEUTICALS INC (Subject) CIK: 0001454815 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90678 | Film No.: 20607479